DOTA-GA(tBu)4 is a protected derivative of a DOTA-based chelating agent, featuring tert-butyl ester protecting groups. It serves as a precursor in the synthesis of chelating agents used in research applications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 306776-79-4
(S)-4-(4,7-Bis(2-(tert-butoxy)-2-oxoethyl)-1,4,7-triazonan-1-yl)-5-(tert-butoxy)-5-oxopentanoic acid
research compound
(R)-NODAGA-tris(t-Bu ester)
pharmaceutical intermediate
2,4-di(tert-butoxy)pyrimidin-5-ylboronic acid hydrate
research compound
Cu-TMEDA catalyst
research compound
5-Bromopyridine-2-carboxylic acid
research compound
N-acetyl-L-isoleucine
research compound
Tri-tert-butyl 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate
research compound
Cyclen
pharmaceutical intermediate
5-[(2-methylpropan-2-yl)oxy]-5-oxo-4-[4,7,10-tris[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-1,4,7,10-tetrazacyclododec-1-yl]pentanoic acid
SUAUFMLRKFUOID-UHFFFAOYSA-N
CC(C)(C)OC(=O)CN1CCN(CCN(CCN(CC1)CC(=O)OC(C)(C)C)C(CCC(=O)O)C(=O)OC(C)(C)C)CC(=O)OC(C)(C)C